Scarica l'app Stockscreener
27.54
1.25%
0.34
Dopo l'orario di chiusura:
27.51
-0.03
-0.11%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Royalty Pharma Plc Borsa (RPRX) Ultime notizie
Royalty Pharma (NASDAQ:RPRX) Raised to “Buy” at StockNews.com - Defense World
Royalty Pharma plc and Syndax Pharmaceuticals Enter into $350 Million Royalty Funding Agreement for Niktimvo - Marketscreener.com
Royalty Pharma (NASDAQ:RPRX) Raised to "Buy" at StockNews.com - MarketBeat
Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo - The Manila Times
Syndax secures $350 million in royalty funding from Royalty Pharma By Investing.com - Investing.com UK
With 72% ownership, Royalty Pharma plc (NASDAQ:RPRX) boasts of strong institutional backing - Simply Wall St
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by abrdn plc - MarketBeat
Trend Tracker for (RPRX) - Stock Traders Daily
Cannon Global Investment Management LLC Purchases Shares of 34,500 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Blue Trust Inc. - Defense World
Unveiling Royalty Pharma (RPRX) Q3 Outlook: Wall Street Estimates for Key Metrics - Yahoo Finance
Royalty Pharma plc (NASDAQ:RPRX) Receives $41.67 Consensus Price Target from Brokerages - Defense World
Royalty Pharma (NASDAQ:RPRX) Rating Lowered to Hold at StockNews.com - Defense World
Royalty Pharma (RPRX) Reports Next Week: Wall Street Expects Earnings Growth - Nasdaq
Royalty Pharma (RPRX) to Release Earnings on Wednesday - MarketBeat
Allspring Global Investments Holdings LLC Reduces Stock Position in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Signaturefd LLC Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX) - Defense World
Royalty Pharma plc (NASDAQ:RPRX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
China Universal Asset Management Co. Ltd. Acquires 33,206 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Cut to Hold at StockNews.com - MarketBeat
Royalty Pharma (NASDAQ:RPRX) Price Target Lowered to $40.00 at Citigroup - MarketBeat
Raymond James & Associates Purchases 71,402 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Keene & Associates Inc. Buys Shares of 19,050 Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Why Southern, Xcel Energy And Royalty Pharma Are Winners For Passive Income - Yahoo Finance
Royalty Pharma plc (NASDAQ: RPRX) Drops -1.14% In Early Trade; What Lies Ahead? - Stocks Register
3 Dividend Growth Stocks to Buy Now for a Lifetime of Passive Income - The Motley Fool
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Marathon Asset Management Ltd - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Truist Financial Corp - Defense World
Paragon Capital Management Inc. Sells 49,241 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma to Announce Third Quarter 2024 Financial Results on November 6, 2024 - The Manila Times
Sanctuary Advisors LLC Invests $649,000 in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Will Royalty Pharma (RPRX) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Royalty Pharma (NASDAQ:RPRX) Has Affirmed Its Dividend Of $0.21 - Simply Wall St
Royalty Pharma's (NASDAQ:RPRX) Dividend Will Be $0.21 - Yahoo Finance
(RPRX) Technical Data - Stock Traders Daily
Royalty Pharma plc (NASDAQ:RPRX) Plans $0.21 Quarterly Dividend - MarketBeat
Royalty Pharma announces Q4 dividend of $0.21 per share - Investing.com India
How does Royalty Pharma plc (RPRX) change from a tortoise to a hare? - SETE News
Royalty Pharma announces Q4 dividend of $0.21 per share By Investing.com - Investing.com South Africa
Royalty Pharma Declares Fourth Quarter 2024 Dividend - ForexTV.com
Royalty Pharma plc (RPRX) Declares $0.21 Quarterly Dividend; 3.1% Yield - StreetInsider.com
RPRX’s Market Whiplash: -1.82% YTD Decline, -1.71% Plunge in 30 Days - The InvestChronicle
3 Biotech Stocks With Huge Upside Based on Analyst Price Targets - Inkl
Understanding the Risks of Investing in Royalty Pharma plc (RPRX) - Knox Daily
Royalty Pharma plc (RPRX): Among The Stocks With Biggest Upside Potential According to Hedge Funds - Insider Monkey
Earnings Tell The Story For Royalty Pharma plc (NASDAQ:RPRX) - Simply Wall St
SG Americas Securities LLC Has $1.76 Million Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma shares retain Buy rating on sustainable growth By Investing.com - Investing.com UK
Mackenzie Financial Corp Sells 18,742 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
10 Stocks with Biggest Upside Potential According to Hedge Funds - Insider Monkey
Sei Investments Co. Buys 31,055 Shares of Royalty Pharma plc (NASDAQ:RPRX) - Defense World
The Manufacturers Life Insurance Company Sells 2,934,926 Shares of Royalty Pharma plc (NASDAQ:RPRX) - MarketBeat
Royalty Pharma plc (NASDAQ:RPRX) Receives $42.00 Consensus Price Target from Analysts - MarketBeat
Dimensional Fund Advisors LP Purchases 139,761 Shares of Royalty Pharma plc (NASDAQ:RPRX) - Defense World
2.02%
0.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):